森沙夫定

化合物

森沙夫定(英語:Censavudine,開發代碼:BMS-986001,也稱為4'-乙炔基司他夫定,4'-ethynylstavudine)是一種含氮有機化合物,化學式為C12H12N2O4,由百時美施貴寶作為HIV抑制劑開發。[1][2]

森沙夫定
臨床資料
其他名稱4'-ethynylstavudine, festinavir
法律規範狀態
法律規範
  • Investigational
識別資訊
  • 1-[(2R,5R)-5-ethynyl-5-(hydroxymethyl)-2H-furan-2-yl]-5-methylpyrimidine-2,4-dione
CAS號634907-30-5
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
NIAID ChemDB
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.225.812 編輯維基數據鏈接
化學資訊
化學式C12H12N2O4
摩爾質量248.24 g·mol−1
3D模型(JSmol英語JSmol
  • CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@](O2)(CO)C#C
  • InChI=1S/C12H12N2O4/c1-3-12(7-15)5-4-9(18-12)14-6-8(2)10(16)13-11(14)17/h1,4-6,9,15H,7H2,2H3,(H,13,16,17)/t9-,12+/m1/s1
  • Key:OSYWBJSVKUFFSU-SKDRFNHKSA-N

參考文獻

編輯
  1. ^ Wu VH, Smith RA, Masoum S, Raugi DN, Ba S, Seydi M, et al. MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture. Antimicrobial Agents and Chemotherapy. August 2017, 61 (8). PMC 5527656 . PMID 28559249. doi:10.1128/AAC.00744-17. 
  2. ^ Gupta SK, McComsey GA, Lombaard J, Echevarría J, Orrell C, Avihingsanon A, et al. Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial. The Lancet. HIV. January 2016, 3 (1): e13–22. PMID 26762988. doi:10.1016/S2352-3018(15)00231-3. hdl:1805/10552 .